Mad Money Uncovered...
Health Care: Drugs
Inovio Pharmaceuticals Inc. (INO: AMEX)
$0.68 0.01 | 0.89%
05/20/13 - 03:59 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with INO
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- UserCore and Growth Portfolio
- UserWatch
- ContributorStocks Under-$10 Setting Up...
- Uservlady 1
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE HOT STOCKS (BUY ...
- UserAjit Kumar Portfolio 2
- Userraju singh Portfolio 1
- Userdragan municipal incorporation
Latest INO Headlines from TheStreet
- Investing Ideas For Flu Season 11.28.12 | 05:11 pm
- 5 Stocks Under $10 Set to Soar 10.18.12 | 12:10 pm
- 5 Stocks Setting Up to Break Out 12.28.11 | 02:12 pm
- Allied Irish Banks, Bell Microproducts: Early Volume Plays 03.29.10 | 07:03 am
- DryShips, Synovus: Late Volume Plays 11.20.09 | 03:11 pm
- Swine Flu Biotech Bubble Primed to Burst 09.10.09 | 11:09 am
- Osiris Stem Cell Drug Fails: BioBuzz 09.08.09 | 08:09 am
- Inovio's CEO Defends Swine Flu Drug (Part 2) 08.07.09 | 02:08 pm
- Inovio Digs for Truffles With Swine-Flu Drug (Part 1) 08.07.09 | 02:08 pm
- Stock Search: Citigroup, Bank of America, Ford 08.03.09 | 12:08 pm
Press Releases for INO
- Inovio Pharmaceuticals DNA Vaccine Against Ebola And Marburg Filoviruses Provides Complete Protection In Preclinical Challenge Study - PR Newswire 05.14.13 | 09:05 am
- Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable To Conventional Vaccine In Phase I Study - PR Newswire 04.18.13 | 12:04 pm
- Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" And "Best Early Stage Biotech" Awards At World Vaccine Congress 2013 - PR Newswire 04.18.13 | 04:04 am
- Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant To Further Develop Mass Vaccination Device - PR Newswire 04.10.13 | 09:04 am
- Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results From ChronVac-C Vaccine For Hepatitis C Infection - PR Newswire 04.02.13 | 04:04 am
- Inovio Pharmaceuticals To Present At BioCentury's "Future Leaders In The Biotech Industry" Conference - PR Newswire 03.28.13 | 04:03 am
- Inovio Pharmaceuticals Closes $15.1 Million Offering Of Common Stock And Warrants - PR Newswire 03.12.13 | 04:03 pm
- Inovio Pharmaceuticals Prices $15.1 Million Offering Of Common Stock And Warrants - PR Newswire 03.07.13 | 06:03 am
- Inovio Pharmaceuticals To Present At The Cowen & Company Health Care Conference - PR Newswire 02.27.13 | 04:02 am
- Inovio Pharmaceuticals, Inc. Investor Presentation Now Available For On-demand Viewing At RetailInvestorConferences.com - PR Newswire 02.11.13 | 07:02 am
Partner Headlines for INO
- Stock Watch Thursday, 11 April 2013 - Seeking Alpha 04.11.13 | 09:04 am
- This Could Be The Coming Out Year For Inovio Pharmaceuticals - Seeking Alpha 01.22.13 | 09:01 am
- Stock Watch Tuesday, 8 January - Seeking Alpha 01.08.13 | 09:01 am
- Stock Watch Wednesday, 2 January - Seeking Alpha 01.02.13 | 08:01 am
- Stock Watch Tuesday, 18 December - Seeking Alpha 12.18.12 | 08:12 am
- 5 Pharmaceutical Companies With Insider Buying During August 14-16 - Seeking Alpha 08.19.12 | 05:08 am
- Investment Potential In Electroporation Companies - Seeking Alpha 07.17.12 | 09:07 am
- Weekly CFO Buys Highlight: ZBB, INO, LPR, PMC, FGP, PRMW - GuruFocus 06.17.12 | 02:06 pm
- Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO - GuruFocus 06.11.12 | 01:06 pm
- Inovio Pharmaceuticals Synthetic DNA Vaccine Protects Against HIV in Non-Human Primates - Benzinga 07.05.11 | 09:07 am
